Effects of losartan on cardiovascular morbidity and mortality in patients with isolated systolic hypertension and left ventricular hypertrophy: A Losartan Intervention For Endpoint reduction (LIFE) substudy Academic Article uri icon

Overview

MeSH Major

  • Antihypertensive Agents
  • Atenolol
  • Cardiovascular Diseases
  • Hypertension
  • Hypertrophy, Left Ventricular
  • Losartan

abstract

  • These data suggest that losartan is superior to atenolol for treatment of patients with isolated systolic hypertension and ECG-LVH.

publication date

  • September 25, 2002

Research

keywords

  • Academic Article

Identity

Language

  • eng

PubMed ID

  • 12243636

Additional Document Info

start page

  • 1491

end page

  • 8

volume

  • 288

number

  • 12